SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022926
Filing Date
2024-09-05
Accepted
2024-09-05 16:35:08
Documents
1
Period of Report
2024-09-04

Document Format Files

Seq Description Document Type Size
1 form4-09052024_040905.html 4  
1 form4-09052024_040905.xml 4 4189
  Complete submission text file 0001415889-24-022926.txt   5781
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O IN8BIO, INC. 79 MADISON AVENUE NEW YORK NY 10016
Business Address
Lamb Lawrence (Reporting) CIK: 0001830059 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39692 | Film No.: 241281858